University of Minnesota. Driven to Discover.
TFAH rated 26 states and Washington, D.C., as 6 or lower on a 10-point scale.
The most common pathogens not properly inactivated were Bacillus anthracis and Francisella tularensis.
FDA.Report to the commissioner: FDA review of the 2014 discovery of vials labeled “Variola” and other vials discovered in an FDA-occupied building on the NIH campus. Dec 13, 2016
GAO. High-containment laboratories: comprehensive and up-to-date policies and stronger oversight mechanisms needed to improve safety. GAO-16-305. Apr 19, 2016
GAO. High-containment laboratories: improved oversight of dangerous pathogens needed to mitigate risk. GAO-16-642 Sep 21, 2016
Larsen JC, Disbrow GL. Project BioShield and the Biomedical Advanced Research Development Authority: a ten year progress report on meeting U.S. preparedness objectives for threat agents. Clin Infect Dis 2017 (published online Feb 4)
NAS. The nation's medical countermeasure stockpile: opportunities to improve the efficiency, effectiveness, and sustainability of the CDC Strategic National Stockpile: workshop summary. Jun 28, 2016
TFAH. Ready or not: protecting the public's health from diseases, disasters and bioterrorism 2016 . Dec 20, 2016
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyAcademic Health Center, University of Minnesota, Minneapolis, MN
© 2017 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.